LMR Partners’s AnaptysBio ANAB Stock Holding History

LMR Partners’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-213,300	Closed	-$2.82M	–	1355
2024 Q4	$2.82M	Buy	+213,300	New	+$5.17M	0.02%	515

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LMR Partners's ANAB Position: Q1 2025 in Review

LMR Partners sold out of AnaptysBio (ANAB) in Q1 2025, closing a stake of 140,722 shares — an estimated $1.86M sold.

LMR Partners first reported a position in ANAB in Q4 2019 and held it in 3 quarters. The position peaked at $1.86M in Q4 2024. 153 funds tracked by Wall St. Rank hold ANAB as of Q1 2025.

LMR Partners reported no remaining AnaptysBio position as of Q1 2025 after selling out during the quarter.
LMR Partners sold 140,722 AnaptysBio shares in Q1 2025, an estimated $1.86M.
LMR Partners first reported a position in AnaptysBio in Q4 2019 and held it in 3 quarters.
LMR Partners's AnaptysBio position peaked at $1.86M in Q4 2024.
153 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2025.

Based on LMR Partners's 13F filing for Q1 2025, filed 15 May 2025.